Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...
"Trump represents an unprecedented threat to America," Altman wrote in 2016. The day after President Donald Trump returned to office, Sam Altman, the CEO of tech giant OpenAI, stood behind the ...
The price of Worldcoin jumped Wednesday, leading the crypto market after OpenAI's $500 billion AI initiative was unveiled.
OpenAI CEO Sam Altman downplayed the significance of a new artificial intelligence (AI) model released by Chinese startup DeepSeek on Thursday, saying it did a “couple of nice things” but has ...
OpenAI CEO Sam Altman posted a picture of himself with Microsoft CEO Satya Nadella on Tuesday and suggested their relationship is going well. Altman wrote that the "next phase" of their ...
"Cut your expectations by 100x," says Sam Altman, who also recently predicted superintelligence was just "a few thousand days ...
Sam Altman's OpenAI launched ChatGPT Gov on Tuesday, which the company said government agencies could use to input sensitive information. Sam Altman hailed the Chinese firm's low-cost AI model ...